Fundación Gecp

This study tested a combination of two immunotherapy drugs, atezolizumab and bevacizumab, as a first treatment for people with a specific type of advanced non-small cell lung cancer. The main goal was to see how long the treatment could keep the cancer from getting worse. The tri…

This study tested whether the experimental drug M7824 (bintrafusp alfa) could help control advanced mesothelioma that had worsened after standard chemotherapy. The trial involved 47 patients with this aggressive lung-related cancer who received M7824 through an IV every two weeks…

This study aimed to understand how people with lung cancer develop and maintain immunity after getting COVID-19 or receiving a COVID-19 vaccine. Researchers observed nearly 2,000 patients across Spain, checking their blood for protective antibodies at different times. The goal wa…

This study aimed to understand how lung cancer affects patients' sexual health. Researchers surveyed 553 lung cancer patients to learn about the types, frequency, and severity of sexual problems they experience. The goal is to use this information to create better support strateg…